Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Spectrum Pharma Inc (NQ: SPPI)
10.60 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:35 AM EST, Dec 19, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 10.60
Bid (Size) 10.00 (6)
Ask (Size) 11.70 (1)
Prev. Close 10.60
Today's Range 10.60 - 10.60
52wk Range 10.44 - 25.29
Shares Outstanding 104,055,102
Dividend Yield N/A
Performance
YTD
-44.39%
-44.39%
1 Month
-18.96%
-18.96%
3 Month
-48.06%
-48.06%
6 Month
-46.89%
-46.89%
1 Year
-46.87%
-46.87%
Top News
More News
Report: Exploring Fundamental Drivers Behind CVS Health, TransCanada, Nektar Therapeutics, LendingTree, Spectrum Pharmaceuticals, and TripAdvisor — New Horizons, Emerging Trends, and Upcoming Developm
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of CVS Health Corporation... Read More
from GlobeNewswire News Releases
Spectrum Pharmaceuticals Announces Results from the RECOVER Phase 3 Study of ROLONTIS® (eflapegrastim) at the 2018 SABCS Annual Meeting
Spectrum Pharmaceuticals Announces Results from the RECOVER Phase 3 Study of ROLONTIS® (eflapegrastim) at the 2018 SABCS Annual Meeting Read More
from Business Wire News Releases
More News
Read More
Spectrum Pharmaceuticals Announces Positive Results from Phase 2 Trial Evaluating Use of Oral Leucovorin to Potentially Mitigate Mucositis in Patients Treated with FOLOTYN® (pralatrexate)
from Business Wire News Releases
Spectrum Pharmaceuticals Highlights Three Posters at the 60th Annual Meeting of the American Society of Hematology
from Business Wire News Releases
Spectrum Pharmaceuticals Appoints Dr. Jeffrey Vacirca to its Board of Directors
from Business Wire News Releases
Analysis: Positioning to Benefit within Spectrum Pharmaceuticals, Carnival, Cadence Design, Tandem Diabetes Care, Rigel Pharmaceuticals, and Regeneron Pharmaceuticals — Research Highlights Growth, Rev
from GlobeNewswire News Releases
Spectrum Pharmaceuticals Reports Third Quarter 2018 Pipeline Update and Financial Results
from Business Wire News Releases
Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2018 London Healthcare Conference on November 14
from Business Wire News Releases
Spectrum Pharmaceuticals Announces Third Quarter 2018 Financial Results Teleconference and Webcast
from Business Wire News Releases
Here's Why Spectrum Pharmaceuticals Rose 21.5% in November
category Market News , SPPI
from Motley Fool
Week In Review: China Pharmas Announce Deals Worth $1.5 Billion
category Stocks / Equities , Pharma/Biotech
from Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.